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ReviewThe taming of PARP1 and its impact on NADþ
metabolismSarah Hurtado-Bagès 1,2,7, Gunnar Knobloch 3,8, Andreas G. Ladurner 3,4,5,**, Marcus Buschbeck 1,6,*ABSTRACT
Background: Poly-ADP-ribose polymerases (PARPs) are key mediators of cellular stress response. They are intimately linked to cellular
metabolism through the consumption of NADþ. PARP1/ARTD1 in the nucleus is the major NADþ consuming activity and plays a key role in
maintaining genomic integrity.
Scope of review: In this review, we discuss how different organelles are linked through NADþ metabolism and how PARP1 activation in the
nucleus can impact the function of distant organelles. We discuss how differentiated cells tame PARP1 function by upregulating an endogenous
inhibitor, the histone variant macroH2A1.1.
Major conclusions: The presence of macroH2A1.1, particularly in differentiated cells, raises the threshold for the activation of PARP1 with
consequences for DNA repair, gene transcription, and NADþ homeostasis.
 2020 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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RIBOSE SIGNALING
The covalent linkage of adenosine diphosphate (ADP)-ribose units to
effector molecules such as proteins, nucleic acids, or small molecules
is a reversible, evolutionarily conserved chemical modification found in
all kingdoms of life (reviewed in [1]). The ADP-ribosylation of proteins,
a post-translational modification, has been implicated in many phys-
iological processes, including gene transcription, protein degradation,
cell proliferation and differentiation, DNA damage and repair, aging,
inflammation, cell death, hostevirus interactions, and metabolism [2e
6]. The reaction is catalyzed by ADP-ribosyltransferases (ARTs) that
include most members of the poly-ADP-ribose polymerase (PARP)
family of proteins as well as some members of the sirtuin family [7,8].
Although PARPs and sirtuins differ substantially in their protein
structure, they both use NADþ as a substrate (Figure 1). Unlike PARPs,
the majority of sirtuins use NADþ for deacetylation and not ADP-
ribosylation. This study focuses on PARPs. The function of sirtuins
and their crosstalk with PARPs was previously reviewed elsewhere
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The PARP family of ARTs, also known as ARTD [12], catalyzes the
modification of proteins through the addition of one or more ADP-
ribose groups (Figure 1). In humans, 17 members of this family of
enzymes have been identified and are classified according to their
activity [13]: PARP1, 2, 5a, and 5b catalyze the polymerization of ADP-
ribose units (PARylation) into linear or branched chains through a(1e2)
O-glycosidic bonds of neighboring ribose moieties. All other PARPs
with the exception of PARP9 and PARP13 catalyze the addition of single
ADP-ribose units onto target proteins through a process that is
generally referred to as mono-ADP-ribosylation or MARylation. To date,
no enzymatic activity has been detected for PARP9 and PARP13 [7]. In
addition to their conserved catalytic ART domain, PARPs contain
additional structural domains that confer distinct localizations and
functions or tightly regulate their spatiotemporal activity [14]. Based on
their domain architecture, PARPs can be sub-divided into four groups:
DNA-dependent PARPs 1e3, ankyrin repeat containing tankyrases
PARP5a and b, Cys-Cys-Cys-His zinc finger containing PARP7,
PARP12, and PARP13, and macrodomain containing PARPs 9, 14, and
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Figure 1: PARPs catalyze poly-ADP-ribosylation. Several members of the PARP family are able to generate linear and branched ADP-ribose chains. PARP1 provides the major
PARP activity in the nucleus. It transfers the ADP-ribose moiety of NADþ onto substrates that can be other ADP-ribose units (poly-ADP-ribosylation) or proteins. Nicotinamide is the
side product of this reaction.
ReviewPARP1, a nuclear enzyme with diverse cellular functions ranging from
DNA repair, transcriptional control, genome stability, and cell death
(reviewed in [15]).
1.2. Activation of PARP1 by DNA damage
The PARP1 protein consists of multiple functional domains: an N-ter-
minal DNA binding domain composed of three zinc finger motifs (Zn1-
3), an auto-modification domain, and the C-terminal ART domain. The
catalytic ART domain is further composed of a conserved tryptophan,
arginine, and glycine-rich WRG domain and a regulatory helical domain
(HD). The HD inhibits substrate binding to the catalytic ART domain
[16]. The zinc fingers Zn1 and Zn2 are sequence-independent sensors
of DNA strand breaks that recruit PARP1 to a variety of DNA damage
structures, including double strand breaks (DSB) and nicked or gapped
single strand breaks (reviewed in [17]). The binding of Zn1 and Zn2 to
DNA creates a domainedomain interaction surface that directs the
structural rearrangement of the remaining enzyme into its activated
conformation, ultimately resulting in a destabilization of the auto-
inhibitory HD domain and allowing NADþ binding to the catalytic site
[18]. The fully activated PARP1 subsequently modifies itself and target
proteins with long, branched PAR chains that can span up to 200 ADP-2 MOLECULAR METABOLISM 38 (2020) 100950  2020 The Authors. Published by Elsevier GmbH. Tribose moieties in length [19]. This creates an interaction scaffold for
PAR binding DNA repair proteins that are recruited to the sites of
PARP1 activity. These include important DNA repair factors such as
XRCC1, APLF, CHFR, MRE11, and ATM that can be attracted to PAR
synthesis sites through their linear, low-complexity PAR binding motifs
(summarized in [20]). It has also been proposed that high local PAR
concentrations can induce a compartmentalization at the DNA break
through liquideliquid phase separation, attracting positively charged
intrinsically disordered proteins such as the FET family of RNA binding
proteins, which are required for DNA repair [21]. “Reader” proteins
containing macrodomains, PAR binding zinc finger (PBZ) domains, or
tryptophan containing WWE domains specifically recognize mono- or
poly-ADP-ribosylation through the direct engagement of the PAR
polymer in their binding pockets (reviewed in [22]). In addition to the
highly specific interaction of PAR reader modules with PAR nucleic
acid, the high density of negative charges in the PAR chains leads to
chromatin expansion and can dissociate DNA from histone octamers
and release PARP1 from DNA damage sites, which downregulates the
activity of the PARP1 enzyme [23]. Several studies clearly showed that
the compact chromatin structure is additionally relaxed by the
recruitment of specific chromatin remodeling enzymes such as ALC1/his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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CHD1L or CHD2 that promote chromatin expansion [24,25] and in-
crease accessibility of DNA for repair proteins [26,27]. PAR-activated
signaling is finally terminated by the PAR hydrolyzing enzymes PARG
and ARH3 [28,29]. These so-called “erasers” create locally high
concentrations of ADP-ribose that can be converted into ATP by the
pyrophosphatase NUDIX5 [30]. This nuclear ATP source has been
proposed to fuel the DNA repair machinery, chromatin remodeling, and
hormone-induced transcriptional regulation.
1.3. Regulation of PARP1 and its role in transcription
PARP1 is an important mediator of extra- and intracellular stress
signals. The cellular outcome depends on the level of PARP1 activation
and can range from activation of the DNA damage repair machinery to
initiation of cell death [31,32]. In addition to the allosteric activation by
DNA breaks, PARP1 activity is subjected to regulatory mechanisms
through post-translational modifications and proteineprotein in-
teractions. Methylation by Set7/9 [33], phosphorylation by ERK1/2 [34],
or its interaction with phosphorylated ERK2 [35] increase PARP1 ac-
tivity. In contrast, the interaction of PARP1 with HPF1 promotes the
PARylation of histones, reduces its auto-modification activity, and
generally shifts the specificity of PARP1 from glutamate, aspartate, and
lysine residues to serines as main PAR acceptor sites [36,37]. As
further discussed in Section 4, histone variant macroH2A1.1 dampens
PARP1 activity by binding its auto-modified form [38,39].
An additional important function of PARP1 is its role as a transcriptional
regulator. Two general mechanisms have been proposed for the
function of PARP1: (1) by regulation of the local and higher order
chromatin structure through direct interaction with nucleosomes or
PARylation of histones and chromatin-associated factors, and (2) as a
co-regulator through interactions with the transcriptional machinery or
sequence specific transcription factors [6,40]. While most studies
show a requirement of PARP1 catalytic activity for its transcriptional
function [41,42], others reported transcriptional modulation indepen-
dent of PARP activity [43].
In sum, PARP1 is an abundant nuclear enzyme whose stress-induced
activation during transcription or DNA damage leads to dramatic al-
terations in nuclear structure and function and is closely intertwined
with cellular metabolism through the consumption of NADþ.
2. NADþ METABOLISM
Nicotinamide adenine dinucleotide (NADþ) is an essential cofactor
involved in most reductive-oxidative metabolic pathways including
glycolysis and the citric acid cycle (reviewed in [44]). NADþ and its
reduced form NADH function as acceptor and donor molecules of two
electrons and one proton. In the mitochondria, this function allows the
coupling of the citric acid cycle to the electron transport chain, which is
essential for the efficient conversion of nutrients into energy. The
membrane potential generated by the electron transport chain drives
oxidative phosphorylation generating adenosine triphosphate (ATP).
In addition to its function in redox reactions, NADþ serves as an ADP-
ribose donor for enzymes regulating important biological processes
such as transcriptional regulation, calcium signaling, and DNA repair
(reviewed in [45]). These enzymes include PARPs, the deacetylase
family of sirtuins, and synthetases generating the second messenger
cyclic ADP-ribose. In this section, we briefly discuss the synthesis of
NADþ and the relevance of its subcellular compartmentalization for
inter-organelle communication (Figure 2). Those interested in the
nutritional aspects of NADþ and the possibilities for pharmacological
intervention should refer to two previous reviews [44,45].MOLECULAR METABOLISM 38 (2020) 100950  2020 The Authors. Published by Elsevier GmbH. This is an open a
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Steady-state cellular NADþ levels are between 200 and 500 mM [44].
Most cells replenish their NADþ pool primarily through a salvage
pathway and to a lesser extent through de novo synthesis from dietary
sources. Dietary sources are nicotinamide (NAM) and nicotinic acid and
are commonly referred to as vitamin B3 and their ribosides and the
amino acid tryptophan [45]. The NADþ salvage pathway allows the
recycling of NAM that is the product generated by NADþ consuming
enzymes. The rate-limiting step is the conversion of NAM into nico-
tinamide mononucleotide (NMN) by nicotinamide phosphoribosyl-
transferase (NAMPT) [46]. Three nicotinamide mononucleotide
adenylyltransferases (NMNAT1-3) catalyze the conversion of NMN to
NADþ. The recycling of one molecule of NADþ from NAM comes at the
cost of two ATP molecules.
2.2. Compartmentalization of NADþ metabolism and synthesis
Most metabolic pathways involving NADþ/NADH-dependent redox
reactions occur in mitochondria and cytosol [45]. In addition to mito-
chondria and cytoplasm, a substantial amount of NADþ is consumed in
the nucleus. Nuclear NADþ consuming enzymes include PARP1,
PARP2, and the sirtuins SIRT1 and SIRT2. Hence, the regeneration of
NADþ through the salvage pathway is compartmentalized (Figure 2).
While the NAMPT enzyme is located in the cytosol and nucleus, the
three NMNAT enzymes have a distinctly subcellular distribution.
NMNAT1 is nuclear, NMNAT2 is located in the cytoplasm and at the
external membrane of the Golgi, and NMNAT3 localizes inside mito-
chondria [47]. Interestingly, PARP1 has been shown to directly interact
with NMNAT1 and recruit it to specific promoter sites where the locally
synthesized NADþ “feeds” the PARP1 catalysis-dependent transcrip-
tional modulation of target genes [48]. Importantly, the NMNATs of all
cell compartments compete for the same pool of NMN produced by
NAMPT thereby placing the intermediate in a central position of linking
NADþ metabolism of different compartments. This is illustrated by the
observation that glucose-induced upregulation of cytosolic NMNAT2 in
adipogenic cells leads to reduced availability of NADþ in the nucleus
with consequences for PARP1-mediated gene regulation and cell dif-
ferentiation [49].
In conclusion, reactions catalyzed by PARPs, sirtuins and cyclic ADP-
ribose synthetases consume NADþ while redox reactions do not
change the overall pool of the NADþ/NADH pair. Separate NADþ pools
exist in compartments and organelles. They are dynamic and
communicate through common precursors of the salvage pathway.
3. THE IMPACT OF ACUTE PARP1 ACTIVATION ON
METABOLISM
More than 50 years ago, NMN was shown to induce a nucleotide
polymer when added to liver nuclear extract [50]. This nucleotide
polymer was later shown to be PAR. This was the first indication that
the NADþ salvage pathway, PARP activity, and the generation of PAR
were linked to each other. In eukaryotic cells, PARP1 accounts for the
largest amount of PARP activity in cells and is the major NADþ
consuming entity in the nucleus [51]. Acute activation of PARP1
through hormone stimulation or DNA damage can lead to the depletion
of 50%e80% of total cellular NADþ [52,53]. PARP1 activation is
usually transient and NADþ levels are quickly recovered, within 4e5 h
in cases of hormone stimulation [52]. However, prolonged activation of
PARP1 in cases of persistent stress can impair the energetic balance of
cells [44], leading to severe ATP depletion and triggering apoptosis
[54].ccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 3
Figure 2: NADD metabolism connects cellular sub-compartments. Most cellular NADþ is regenerated through the salvage pathway from NAM and to a smaller extent through
de novo biosynthesis from dietary sources such as NR (nutrient). The rate-limiting reaction from NAM to NMN is catalyzed by NAMPT enzyme in the nucleocytosol. Three different
NMNAT enzymes catalyze the compartmentalized regeneration of NADþ from the same pool of NMN. The NADþ/NADH pair has key redox functions in the tricarboxylic acid (TCA)
cycle and the electron transport chain to drive ATP generation.
ReviewConversely, inhibition of PARP1 can increase energy balance and
improve mitochondrial function. We recently summarized the current
knowledge about PARP1 loss-of-function studies in mice [55].
Although the outcomes were variable and strongly diet and genetic
context dependent, most of these studies suggested that PARP inhi-
bition is metabolically favorable. Pharmacologic PARP inhibitors or
genetic inhibition of PARP1 protect mice from diabetes when induced
by administration of the b-cell toxin streptozotocin [56,57]. Similarly,
both PARP inhibitors and PARP1 knock-out reduce disease parameters
in obesity-challenged mice. This includes reduced diabetes-associated
kidney damage in the genetic Lbdr (db/db) model [58] and protection
against obesity in mice on high-fat diets [59,60].
In several cases, the favorable effect of PARP1 inhibition was
linked to an increased availability of NADþ for other reactions.4 MOLECULAR METABOLISM 38 (2020) 100950  2020 The Authors. Published by Elsevier GmbH. TTreatment of cell cultures with PARP inhibitors increased the
cellular NADþ levels [52,59,61]. Interestingly, increased NADþ
availability frequently leads to higher mitochondrial activity. The
Auwerx Lab showed an indirect effect on respiration exerted by
increased NADþ-dependent SIRT1 activity in the nucleus that is
mediated by the upregulation of genes promoting respiration
[59,62]. Studying differentiated muscle cells, we further found a
direct effect of inhibited PARP1 mediated by increased availability
of the NADþ precursor NMN in the cytosol and increased regen-
eration of NADþ in the mitochondria [39,55].
Taken together, PARP1 activity in the nucleus can affect the meta-
bolism of distant compartments, notably mitochondrial respiration,
through the consumption of NADþ and the depletion of precursors from
common pools. The inhibition of PARP1 is emerging as a potentialhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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therapeutic strategy to modulate NADþ levels and shift NADþ usage to
other reactions and compartments.
4. TAMING OF THE PARP1 STRESS RESPONSE BY THE
HISTONE VARIANT MACROH2A1.1 IN DIFFERENTIATED CELLS
Terminally differentiated and proliferating cells have different re-
quirements for DNA repair and thus for DNA damage-induced PARP1
signaling. While proliferating cells require fast repair until the next
entry into the S-phase, this is much less critical in non-cycling cells
that most likely acquire less DNA damage and might be able to tolerate
it for a prolonged time. As such, in retrospect, it is not surprising that
metazoan species have evolved an inhibitory mechanism dampening
but not abrogating PARP1 signaling in terminally differentiated states.
In the context of chromatin, one of these endogenous inhibitors is the
histone variant macroH2A1.1.
4.1. MacroH2A histone variants
The exchange of a replication-coupled histone for a histone variant is
one of the most drastic changes that can occur on the level of the
nucleosome and endow the immediate chromatin environment with
new structural and biophysical properties [63]. In particular, for H2A
and H3, many histone variants exist. Among these, three macroH2A
histone variants stick out because they have a unique tripartite
structure consisting of a histone-fold domain followed by a C-terminal
unstructured linker connecting with a globular macrodomain [64]. The
linker protrudes from the compact structure of the nucleosome near
the dyad axis and places the macrodomain at an accessible position
outside the chromatin fiber. MacroH2A proteins contribute to epige-
netic regulation in development, differentiation, and somatic cell
reprogramming and cancer. Those interested in these aspects of
macroH2As should refer to two recent reviews in which we provided a
synthesis of the current knowledge [63,65]. As a resource to the field,
we published an overview of loss-of-function studies conducted in
mice highlighting differences in genetic context and experimental
approaches [55]. The molecular mechanism by which macroH2As
mediate their epigenetic function is yet unknown but is likely related to
a major role in regulating higher order chromatin structures including
heterochromatin [66e68].
4.2. MacroH2A1.1 macrodomain binds and inhibits ADP-
ribosylated PARP1
Two genes and one alternative splicing event produce three macroH2A
proteins that differ in their macrodomains [69]. Macrodomains are
ancient globular folds that have a binding pocket for ADP-ribose [70].
The capacity to bind ADP-ribose is limited to the splice variant mac-
roH2A1.1 [68,71]. MacroH2A1.1 differs in only 26 amino acids from
the alternative splice variant macroH2A1.2 [72]. These amino acids
form part of the binding pocket required for ADP-ribose binding [71].
The expression of both variants is tissue specific [72] and mac-
roH2A1.1 is highly expressed in terminally differentiated cells such as
enterocytes and myotubes [39,73]. The binding mode of ADP-ribose
allows macroH2A1.1 to also bind the terminal part of PAR chains
and proteins post-translationally modified by ADP-ribosylation [74].
The latter has been shown for auto-modified PARP1. Although this has
not been formally tested, the ADP-ribose bound structure of the
macrodomain suggests that it would be compatible with binding
mono-ADP-ribosylated proteins. All macroH2As co-purify with PARP1
in the context of purified mono-nucleosomes; however, onlyMOLECULAR METABOLISM 38 (2020) 100950  2020 The Authors. Published by Elsevier GmbH. This is an open a
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associated PARP1 activity [38]. Using in vitro assays, we found that the
macrodomain of macroH2A1.1 is sufficient for inhibiting PARP1 [39]. In
both cases, the inhibitory capacity is strictly dependent on the integrity
of the binding pocket and its capacity to bind ADP-ribose [38,39]. As
such, the PARP inhibitory function is strictly limited to the splice iso-
form macroH2A1.1 (Figure 3). We and others were unable to confirm
an earlier report suggesting that the macrodomains of the other
macroH2A proteins would be able to inhibit PARP1 [75].
At present, it is unclear how exactly auto-modification and mac-
roH2A1.1 binding modulate the activity of PARP1. But as increased
auto-modification correlates with increased activation, it is possible
that auto-modification stabilizes the enzyme in its active conformation.
We can further envision two possible scenarios for how the binding of
macroH2A1.1 ADP-ribosylated to PARP1 interferes with its activity: (i)
The close binding of a single macrodomain to mono-ADP-ribosylated
PARP1 or a form of PARP1 modified with a short PAR chain directly
affects the conformation and activity of the enzyme. (ii) The binding of
the macrodomains to all ends of growing PAR chains deprives PARP1
of access to its target site, which does not allow sufficient auto-
modification to stabilize the active state. A major difference between
these two hypothetical mechanisms is that one-to-one binding would
suffice for the first mechanism while the second would require an
excess of macroH2A1.1 macrodomains. Our observation that close to
equimolar levels of macroH2A1.1 were sufficient to inhibit PARP1 in
myotubes argues for the first and more direct mechanism [39]
(Figure 3). In cases where macroH2A1.1 is present at lower levels than
PARP1 or in situations where the PARP1-activating stimulus is too
strong, endogenous inhibition is not expected to occur. However,
macroH2A1.1 would still be able to recruit active and auto-modified
forms of PARP1 with longer, multiple, and branched PAR chains to
genomic loci (Figure 3). This has the potential to explain how mac-
roH2A1.1 cooperates with PARP1 in gene regulation [38,42] as well as
in DNA repair. Two examples of the latter are the promotion of cell
survival in response to ionizing radiation [76] and the repair of oxidative
damage [77]. Taking all these studies together, the relative ratio of
macroH2A1.1 and PARP1 decides whether macroH2A1.1 acts as in-
hibitor or cooperative partner of PARP1. Inhibition is limited to situa-
tions in which the level of macroH2A1.1 is equal or exceeds the level of
PARP1.
4.3. MacroH2A1.1 couples differentiated state and NADþ
metabolism
We studied the PARP inhibitory function of macroH2A1.1 during the
terminal differentiation of myoblasts to myotubes. Our study suggested
that this endogenous inhibition operates in terminally differentiated
myotubes but not in proliferating myoblasts [39]. We found that
macroH2A1.1 is barely expressed in fast proliferating cells [78] but
rapidly upregulated through a switch in alternative splicing during
myogenic differentiation, reaching levels matching those of PARP1
[39]. Inhibition of PARP1 by macroH2A1.1 leads to decreased NADþ
consumption in the nucleus and sustained levels of the precursor NMN.
This in turn leads to increased pools of mitochondrial NADþ and
improved oxidative phosphorylation. The upregulation of macroH2A1.1
allows differentiated muscle cells to avoid unnecessary NADþ con-
sumption in the nucleus, prioritizing its use in the mitochondria for ATP
production and cell survival. Several lines of observation suggest that
this mechanism is general and not limited to muscle tissue. First,
macroH2A1.1 is also upregulated during differentiation of other cellccess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 5
Figure 3: MacroH2A1.1 is an endogenous inhibitor of PARP1. NMNAT1 acts as feeder providing NADþ to PARP1. Activation of PARP1 is accompanied by auto-modification.
Binding of the “tamer” macroH2A1.1 leads to its inhibition. The taming can be overcome by PARP1 hyperactivation and hypermodification. Proteins containing poly-ADP-ribose
(PAR) interaction domains including macrodomains can act as readers of the ADP-ribose units. PARG and ARH3 are the erasers that remove PAR chains.
Reviewtypes including embryonic stem cells, colon cancer cells, and adipo-
cytes [73,78,79]. Second, the overexpression of macroH2A1.1 but not
macroH2A1.2 in liver cells prevented the accumulation of fat most
likely by promoting its oxidation in mitochondria [80,81].
Taken together, differentiating cells have evolved an elegant mecha-
nism coupling new energetic requirements of terminal differentiation to
a change in chromatin composition, setting a higher threshold for
PARP1 activation and nuclear NADþ consumption. High levels of
macroH2A1.1 inhibit PARP1, but the exact molecular mechanism of
this taming remains to be elucidated.
5. CONCLUSION AND OUTLOOK
Organisms have co-evolved mechanisms governing genome stability,
transcriptional regulation, and metabolic homeostasis. It is not sur-
prising that these mechanisms are interconnected. Shared metabolites
are able to communicate states between distant organelles. It is now
well accepted that NADþ metabolism plays a major role in commu-
nication between the nucleus and mitochondria [44,45]. While the6 MOLECULAR METABOLISM 38 (2020) 100950  2020 The Authors. Published by Elsevier GmbH. Tnucleus is responsible for all reactions using genomic DNA as a
template, mitochondria are the cells’ major energy source. As such, it
is not surprising that cells have evolved mechanisms to coordinate the
activities of both organelles. Although mitochondria are a clearly
separate metabolic compartment, they are connected to the nucleo-
cytosolic compartment through reliance on NMN as a common pre-
cursor of NADþ. However, it is still unclear how exactly NMN enters the
mitochondria. Another important question is whether alternative
pathways and resources exist that can replenish the mitochondrial
NADþ pool. Novel fluorescence-based methods that enable measuring
NADþ levels in different compartments in situ will be very helpful to
answer these questions [82]. Future work will need to address the
question, which metabolites other than NMN act as signaling mole-
cules between distant compartments?
A challenge for the PARP field is the development of methods that
enable the detection of low or basal enzymatic activity. The mea-
surement of PARP-1 activity in cells relies on the detection of its
product, the instable PAR polymer that transiently accumulates after
PARP-1 hyperactivation. Under steady-state conditions, the PARhis is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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polymer cannot be detected due to its rapid turnover. While it has been
convincingly shown that acute activation of PARP1 by DNA damage or
other stresses leads to NADþ depletion, much less is known about the
level of basal NADþ consumption. Our study on myotubes suggested
that even in non-cycling differentiated cells without induction of DNA
damage by exogenous agents, basal PARP1 activity exists and if not
blunted by macroH2A1.1 can consume a substantial amount of NADþ
[39]. Compensated by the salvage pathway, this was reflected by a
depletion of the precursor NMN. The exact consequences of auto-MAR
and PARylation for PARP activity remain to be studied and will provide a
better understanding of the molecular basis of PARP1 inhibition by
macroH2A1.1 binding. In this line, it is interesting to note that the linker
of macroH2A1 itself can be ADP-ribosylated on serine 146 [83]. This
leads us to wonder if the linker modification would conversely affect
macroH2A1.1 capacity to bind and inhibit PARP1. Interestingly, the
linker sequences differ between macroH2A1 and macroH2A2.
The involvement of macroH2A histone variants in DNA repair is
complex and future research will need to dissect which functions are
based on the interplay between macroH2A1.1 and PARP1 and which
functions are contributions by other macroH2A isoforms and inde-
pendent of PARP1. PARP1 activation is an early event in the DNA
repair process and its partial inhibition by macroH2A1.1 reduces
PARP1-dependent chromatin expansion [68], avoids DNA damage-
induced NADþ depletion, and alters the dynamics of PAR by delay-
ing its production and increasing its half-life [77]. MacroH2A1.1 is
recruited to PAR [74,84], which can lead to the large-scale reorga-
nization of the chromatin [74] or its local incorporation into the
chromatin surrounding the damaged site [76]. As a consequence of
these functions, macroH2A1.1 promotes cell survival in response to
ionizing radiation [76] and the repair of oxidative damage [77]. In
mice, the genetic ablation of macroH2A1.1 led to a reduction of
hematopoietic stem cells after high-dose irradiation [85]. Functions
more related to later time points of the DNA damage repair process
have been reported for macroH2A1.2. These include a role in the
necessary re-condensation of chromatin in cooperation with the
histone K9 methyltransferase PRDM2 [86]. At fragile sites and
telomeres lengthened through the alternative ALT pathway, the
presence of macroH2A contributes to a protective environment and
promotes DNA repair through homologous recombination [87,88]. It
remains to be tested whether the same domains of macroH2A
mediate both the PARP1-independent functions in DNA repair as well
as the function in regulating heterochromatin architecture [66,68].
For the histone variant community, it will be of great interest to un-
derstand to which extent the function of macroH2A1.1 as an endog-
enous inhibitor of PARP1 is relevant in different tissues and cell types.
Physiological studies in knock-out animals can be expected to provide
important information. More molecular questions are how the PARP1-
related function intersects with the role of macroH2A variants to
regulate nuclear organization and three-dimensional chromatin ar-
chitecture [66,68]. Furthermore, it will be of great interest to under-
stand when the two functions were acquired during evolution.
Interestingly, two other histone variants have been related to metabolic
activity. H2A.X is best known for its role in DNA damage signaling [89]
but also regulates mitochondrial shape, activity, and biogenesis most
likely through sustaining the expression of the key transcriptional
regulator PCG-1 alpha [90]. Overexpression of the macroH2A1.2 iso-
form in mice had a systemic effect on metabolism and reduced fat
mass [91]. Future research will need to examine the contributions
made by different histone variants and to which extent they are
mediated through gene regulation or direct effects on metabolic
reactions.MOLECULAR METABOLISM 38 (2020) 100950  2020 The Authors. Published by Elsevier GmbH. This is an open a
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